Moderna still struggles to convince

Posted

France 3

Article written by

B. Aparis, F. Nicotra, V. Bouffartigue, G. Gheorghita, A. Canestraro – France 3

France Televisions

Moderna vaccine stocks are much larger than Pfizer’s. Many vaccination centers thus tend to favor or impose Moderna, something to worry some patients, who are quite suspicious of this vaccine.

350 people per day are vaccinated in the center of Rueil-Malmaison (Hauts-de-Seine). Here, the name of the serum is debated, and Moderna is not really popular. “It has a less effective reputation”, confides a woman, while another says to herself “not really” worry. “We feel questions, even reluctance for some, explains Odile Barry, the centre’s vaccination manager. We have yesterday and the day before, about 3% of people who refused to be vaccinated with Moderna. “

Since Monday, December 6, a new protocol from the Ministry of Health has been in place for the distribution of vaccines: Pfizer for those under 30, Moderna for those over 30. The minimal risks of developing myocarditis or pericarditis in the youngest should not negate the beneficial aspect of the Moderna vaccine, believes some specialists. “People who refuse to be vaccinated with Moderna make a mistake and take the risk of catching a Covid”, explains Professor Mathieu Molimard, head of the medical pharmacology department of the Bordeaux University Hospital (Gironde), who ensures that “the Moderna vaccine is as effective and with more risk as a booster than the Pfizer vaccine”. France has 5 million doses of Pfizer, and 20 million doses of Moderna.


source site-14